(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLINICAL STRENGTH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CLINICAL STRENGTH

ST13

US500000077290134

Class

3

Filing

77290134

Registration

3621468

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

06/23/2018

Trademark type

Word

Nice classes

3

Filing date

09/27/2007

Registration date

05/19/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/23/2018

Last transaction

06/23/2018

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

02/12/2007

First use in commerce

02/12/2007

Drawing code

4

Owner type

03

Owner location

Cincinnati, OH, US

Examiner

RUTLAND, BARBARA A

Law office

L10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

The Procter & Gamble Company

Representatives

Emily Judge The Procter & Gamble Company

Technical classification

Nice Classes

Class 3

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Antiperspirants; Deodorant for personal use

Publications

History of USPTO decisions and trademark events.

34 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/23/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/23/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/23/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/23/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

06/12/2018

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/19/2018

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/07/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/07/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/16/2014

E815

TEAS SECTION 8 & 15 RECEIVED

10/08/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

05/19/2009

TMBN

TTAB RELEASE CASE TO TRADEMARKS

04/11/2009

OP.T

OPPOSITION TERMINATED NO. 999999

04/11/2009

OP.D

OPPOSITION DISMISSED NO. 999999

04/11/2009

OP.I

OPPOSITION INSTITUTED NO. 999999

03/16/2009

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

10/13/2008

PUBO

PUBLISHED FOR OPPOSITION

09/16/2008

NPUB

NOTICE OF PUBLICATION

08/27/2008

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/12/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/11/2008

RFTP

REMOVED FROM TEAS PLUS

08/09/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/09/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/17/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/16/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/16/2008

ACEC

AMENDMENT FROM APPLICANT ENTERED

07/15/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/15/2008

ALIE

ASSIGNED TO LIE

07/15/2008

MAIL

PAPER RECEIVED

07/10/2008

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/05/2008

GNRT

NON-FINAL ACTION E-MAILED

01/05/2008

CNRT

NON-FINAL ACTION WRITTEN

01/05/2008

DOCK

ASSIGNED TO EXAMINER

12/28/2007

NWAP

NEW APPLICATION ENTERED

10/02/2007

Continuous trademark protection

Get notified about every new filing that threatens CLINICAL STRENGTH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.